Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance
Go back to Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance| Gilead Sciences (NASDAQ: GILD) | Delayed: 150.57 -2.1 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.67 | 52 Week High | $108.63 | |||
| Open | $153.60 | 52 Week Low | $71.39 | |||
| Day High | $154.20 | P/E | 83.19 | |||
| Day Low | $150.22 | EPS | $1.81 | |||
| Volume | 2,209,772 | |||||

